A prospective, multi centre, randomized clinical study to compare the efficacy and safety of Ertapenem 3 days versus Ampicillin - Sulbactam 3 days in the treatment of localized community acquired intra-abdominal infection. (T.E.A. Study: Three days Ertapenem vs three days Ampicillin-sulbactam)

A prospective, multi centre, randomized clinical study to compare the efficacy and safety of Ertapenem 3 days versus Ampicillin - Sulbactam 3 days in the treatment of localized community acquired intra-abdominal infection. (T.E.A. Study: Three days Ertapenem vs three days Ampicillin-sulbactam)

<p>Abstract</p> <p>Background</p> <p>The recommendations outlined in the latest guidelines published by the Surgical Infection Society (SIS) and the Infectious Disease Society of America (IDSA) regarding the proper duration of antibiotic therapy in patients with intra-a...

Full description

Bibliographic Details
Main Authors: Gazzotti Filippo, Di Saverio Salomone, Ercolani Giorgio, Ansaloni Luca, Catena Fausto, Coccolini Federico, Lazzareschi Daniel, Pinna Antonio D
Format: Article
Language:English
Published: BMC 2011-04-01
Series:BMC Gastroenterology
Online Access:http://www.biomedcentral.com/1471-230X/11/42

Internet

http://www.biomedcentral.com/1471-230X/11/42

Similar Items